COVID‐19 and Obesity: The Intersection Between a Pandemic and an Epidemic in a Developing Country
Authors:
- Marcio José Concepción‐ZavaletaMCMarcio José Concepción‐Zavaleta
- Claudia Gutiérrez‐OrtizCGClaudia Gutiérrez‐Ortiz
- Julia Cristina Coronado‐ArroyoJCJulia Cristina Coronado‐Arroyo
- Francisca Elena Zavaleta‐GutiérrezFZFrancisca Elena Zavaleta‐Gutiérrez
- Luis Alberto Concepción‐UrteagaLCLuis Alberto Concepción‐Urteaga
Open Access
Abstract
We have read with great interest the prospective cohort study published by Czernichow et al 1, wherein they found that obesity doubles mortality in patients hospitalized with coronavirus disease (COVID‐19), using as an indicator anthropometric, the body mass index (BMI). Despite BMI being recognized as an anthropometric index of obesity and various studies confirming that it predicts cardiovascular events, the lack of information it provides on the distribution of body fat is considered its main limitation. The use of abdominal circumference and waist‐height ratio are better measures of visceral fat distribution, which is more closely associated with cardiometabolic risk;2 however, those measures demand greater contact with COVID‐19 patients.Keywords
This publication has 5 references indexed in Scilit:
- Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 PatientsObesity, 2020
- Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic CollideMayo Clinic Proceedings, 2020
- Association between anthropometric indicators of obesity and cardiovascular risk factors among adults in Shanghai, ChinaBMC Public Health, 2019
- Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal studyBMJ Open Diabetes Research & Care, 2015
- El problema del sobrepeso y la obesidad en el Perú: la urgencia de una política de Salud Pública para controlarlaRevista Peruana de Medicina Experimental Y Salud Pública, 2012